Cardiac Wire #328 December 11, 2025
TAVR Outcomes Shrug Off CAD, FDA Clearances, and Low IC Match Rates
Cardiac Wire #327 December 8, 2025
Childhood Obesity’s CHD Risks, GLP-1s Wear Off Fast, and CMS News
Cardiac Wire #326 December 4, 2025
How HF is Changing, Cardiac Imaging at RSNA, and Healthcare’s 30/30
Cardiac Wire #325 December 1, 2025
Risk Equations Struggle, OCEANIC-STROKE, and A DoD Canon Contract
Cardiac Wire #324 November 24, 2025
Winrevair’s HF Win, GEHC Buys Intelerad, and Beta-Blockers Post-MI
Cardiac Wire #323 November 20, 2025
Myval’s TAVR LANDMARK, Oral PCSK9i Success, and EchoPrime
Cardiac Wire #322 November 17, 2025
CLOSURE-AF Casts LAAO Doubt and More AHA Highlights
Cardiac Wire #321 November 13, 2025
AHA 2025: The Top Research and Trends
Cardiac Wire #320 November 10, 2025
Lifestyle Post-Ablation, DurAVR IDE, and CagriSema Succeeds
Cardiac Wire #319 November 6, 2025
Stem Cells for HF, UnitedHealthcare Drops RPM, and New Cardiology CMS Fees
Cardiac Wire #318 November 3, 2025
Tendyne Succeeds in MAC, Pfizer vs. Novo, and Atorvastatin Recall
Cardiac Wire #317 October 30, 2025
Top TCT 2025 Trends, Research, and News
Cardiac Wire #316 October 27, 2025
Genetic Risk for CAD, Bodybuilder SCD, and Ancora’s LV Product
Cardiac Wire #315 October 23, 2025
Intensive BP Lowering, Medtronic & DASI, and Docs Leaving Medicare
Cardiac Wire #314 October 20, 2025
HFpEF’s Body Fat Link, Hello Heart, and CVD Eye Detection
Cardiac Wire #313 October 16, 2025
Cardiology Compensation, Biodegradable PFO, and Abbott Buys Laralab
Cardiac Wire #312 October 13, 2025
Specialist HF Care, Constipation & CVD, and NanoPhoria’s Peptide
🫀Cardiac Wire #311 October 9, 2025
Lp(a) Screening is Low, Viz ACS Launch, and AmgenNow
Cardiac Wire #310 October 6, 2025